Idursulfase and urticaria Patient Reports February 12, 2012

Idursulfase Side Effects Report #5765803-X
Idursulfase side effect was reported by a Physician from JAPAN on May 01, 2008. Male patient, child 7 years of age, weighting 61.73 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Idursulfase. After drug was administered, patient experienced the following side effects: erythema, infusion related reaction, morose, salivary hypersecretion, urticaria. Idursulfase dosage: 12 MG, 1X/WEEK, IV DRIP. Patient recovered.

Idursulfase Side Effects Report #6016892-9
Idursulfase side effect was reported by a Physician from JAPAN on Dec 05, 2008. Male patient, child 7 years of age, weighting 61.73 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Idursulfase. After drug was administered, patient experienced the following side effects: anaphylactic reaction, erythema, infusion related reaction, morose, pruritus, salivary hypersecretion, urticaria. Idursulfase dosage: 12 MG, 1X WEEK, IV DRIP. Patient recovered.

Idursulfase Side Effects Report #5389799-8
Idursulfase side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on June 28, 2007. Male patient, child 5 years of age, weighting 39.68 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Idursulfase. After drug was administered, patient experienced the following side effects: infusion related reaction, pruritus, urticaria. Idursulfase dosage: (0.5 MG/KG, 1 IN 1 WK), INTRAVENOUS DRIP. During the same period patient was treated with CAPOTEN. Patient recovered.

Idursulfase Side Effects Report #5331726-3
Idursulfase side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2007. Male patient, child 10 years of age, weighting 60.63 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Idursulfase. After drug was administered, patient experienced the following side effects: anaphylactoid reaction, chest discomfort, erythema, infusion related reaction, urticaria, wheezing. Idursulfase dosage: (13.5 MG, 1 IN 1 WK), INTRAVENOUS DRIP. Patient recovered.